Taken together, our data suggest that the transient up-regulation of maspin in the early development of ESCC may be a defense mechanism against further transition towards more malignant phenotypes, ultimately slowing down ESCC tumor progression. The gene discussed is SERPINB5; the disease is esophageal squamous cell carcinoma.